Actively Recruiting
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
Led by Northwestern University · Updated on 2024-05-29
200
Participants Needed
1
Research Sites
27 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare breast symptoms (lactation, engorgement, etc) of individuals who undergo a procedure for second trimester of pregnancy loss between 16 weeks and 20 weeks gestational age. The participants will be randomly placed in two groups, one with a placebo tablet and one with medication called "cabergoline" which are taken immediately after their procedure. Researchers will compare groups to see if there are any significant differences in breast symptoms.
CONDITIONS
Official Title
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant individuals seeking termination of pregnancy after 16 weeks 0 days and up to 19 weeks 6 days gestation, including management of intrauterine demises
- Age between 18 and 50 years
- Ability to provide informed consent in English
You will not qualify if you...
- Age under 18 or over 50 years
- Gestational age before 16 weeks 0 days or after 20 weeks 0 days
- Unable to provide written consent in English
- Hypertensive disorder or uncontrolled hypertension
- Known hypersensitivity to ergot derivatives
- History of cardiac valvular disorders
- History of pulmonary fibrosis
- Documented bipolar schizophrenia
- Documented allergy to medication, including lactose intolerance (placebo contains lactose)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Northwestern Medical Center
Chicago, Illinois, United States, 60611
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here